[Risk factors for multidrug-resistant Pseudomonas aeruginosa infection, in a tertiary hospital in Colombia]

Rev Chilena Infectol. 2014 Aug;31(4):393-9. doi: 10.4067/S0716-10182014000400003.
[Article in Spanish]

Abstract

Introduction: multi-resistant Pseudomonas aeruginosa (MR) is frequently associated with healthcare infections. Its epidemiology is complex and few studies help to understand it. A study about risk factors associated with this type of bacteria is needed.

Objective: To determine risk factors associated with MR P. aeruginosa infection in hospitalized patients from the Hospital Universitario San Vicente Foundation-Medellin.

Materials and methods: case-control study to identify risk factors associated with infection by MR P. aeruginosa.

Results: 140 patients were included, 70 in each group. Bivariate analysis found association with previous use of carbapenems (OR 3.12 - IC 1.21 to 8.03, p = 0.02), aminoglycosides (OR 5.09 - CI: 1.38 to 18, 77, p = 0.01) and days of stay prior to isolation of the organism (OR 1.03 - CI: 1.01-1.05, p = 0.01). In multivariate analysis MR P. aeruginosa infection was associated with hospital stay (OR 1.03 - IC 1.01 to 1.05), use of aminoglycosides (OR 1.30 to 19.28) and treatment with two or more antimicrobials in the last 30 days (OR 3.09 - CI: 1.26 to 7.58). The risk of developing infection was 3% per day of hospital stay prior to isolation of the agent.

Conclusion: Developing MR P. aeruginosa infection was associated with prior use of antimicrobials and prior hospital stay.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Case-Control Studies
  • Colombia
  • Cross Infection / microbiology*
  • Drug Resistance, Multiple, Bacterial*
  • Female
  • Humans
  • Length of Stay
  • Male
  • Middle Aged
  • Pseudomonas Infections / etiology*
  • Pseudomonas Infections / microbiology
  • Pseudomonas aeruginosa*
  • Risk Factors
  • Tertiary Care Centers